Elevation of soluble CD23 in sera from patients with infectious mononucleosis

Journal of Medical Virology

Volumn 53, Issue 4, 1997, Pages 384-387

  Hashimoto, Shu ^a   Takei, Masami ^a   Gon, Yasuhiro ^a   Sawada, Shigemasa ^a   Maekawa, Naoko ^b   Yodoi, Junji ^b   Takada, Kenzo ^c   Horie, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Infectious mononucleosis; Soluble CD23

Indexed keywords

CD23 ANTIGEN;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; INFECTIOUS MONONUCLEOSIS; MALE; NASOPHARYNX CARCINOMA; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; LYMPHATIC DISEASES; MALE; RECEPTORS, IGE; SOLUBILITY; SPLENOMEGALY; TIME FACTORS;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0031448205     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199712)53:4<384::AID-JMV11>3.0.CO;2-F     Document Type: Article

References (15)

1. Auby JP, Pochon S, Graber T, Jansen KU, Bonnefoy JY (1979): CD21 is a ligand for CD23 and regulates IgE production. Nature 358: 505-507.
2. Caris JA, Godon J (1990): Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblast. European Journal Immunology 20:539-543.
3. Conrad DH (1990): FcεRII/CD23: the low affinity receptor for IgE. Annual Review Immunology 8:623-645.
4. Epstein MA, Achong BG (1979): Discovery and general biology of the virus. In Epstein MA, Achong BG (eds): "The Epstein-Barr virus." Berlin: Springer-Verlag, pp 1-22.
5. Gordon J, Caris JA, Liu YJ, Flores-Romo L, Maclennan ICM, Jansne KU, Bonnefoy JY (1991): A novel multifunctional regulation for the immune system that binds IgE. Monograph in Allergy 29:156-168.
6. 2 monoclonal antibody). Variable regulation depending on the cell types. Journal of Immunology 141:1376-1382.
7. Hashimoto S, Koh K, Tomita Y, Amemiya E, Sawada S, Yodoi J, Horie T (1995): TNF-α-regulates IL-4-induced FcεRII/CD23 gene expression and soluble FceRII release by human monocytes. International Immunology 5:705-713.
8. Lecron JC, Morel F, Tnazer J, Gambert J, Lafrorest PG (1991): Soluble CD23 displays T-cell growth enhancing activity. Immunology 74:561-563.
9. Letellier M, Nakajima T, Pulido-Cejudo G, Hofstetter H, Delespesse G (1990): Mechanism of formation of human IgE-binding factor (soluble CD23): III. Evidence for a receptor (FcεRII)-associated proteolytic activity. Journal of Experimental Medicine 172:693-700.
10. Satio I, Servenius B, Compton T, Fox RI (1989): Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. Journal of Experimental Medicine 169:2191-2198.
11. Sarfati M, Rector E, Rubio-Trujillo M, Wong K, Sehan AH, Delespesse G (1984): In vitro synthesis of IgE by human lymphocytes. III. IgE potentiating activity of culture supernatants from Epstein-Barr virus (EBV) transformed B cells. Immunology 53:207-214.
12. Takei M, Mitamura K, Fujiwara S, Horie T, Ryu J, Osaka S, Yoshino S, Sawada S (1997): Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. International Immunology 9:739-743.
13. Thorley-Lawson DA, Nadler LM, Bhan AK, Schooley RT (1985): BLAST-2 (EBVCS), an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. Journal of Immunology 134:3007-3012.
14. 2 and IgE-BF: Structures and functions of low affinity Fc receptors. Chemical Immunology 47:106-127.
15. Yoshikawa T, Nanba T, Kato H, Hori K, Inamoto T, Kumagai S, Yodoi J (1994): Soluble FcεRII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: Analysis by ELISA for soluble FcεRII/CD23. Immunomethods 4:65-71.